Park West Asset Management LLC Buys Shares of 423,570 Phreesia, Inc. (NYSE:PHR)

Park West Asset Management LLC bought a new stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 423,570 shares of the company's stock, valued at approximately $10,657,000. Park West Asset Management LLC owned about 0.73% of Phreesia as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Northern Trust Corp raised its position in shares of Phreesia by 6.6% during the 4th quarter. Northern Trust Corp now owns 571,807 shares of the company's stock valued at $14,387,000 after acquiring an additional 35,392 shares during the last quarter. Quarry LP increased its position in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares in the last quarter. Johnson Financial Group Inc. increased its position in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares in the last quarter. Greenhouse Funds LLLP increased its position in shares of Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after buying an additional 626,579 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Phreesia by 36.5% in the 4th quarter. Hsbc Holdings PLC now owns 13,064 shares of the company's stock valued at $333,000 after buying an additional 3,493 shares in the last quarter. Institutional investors own 92.10% of the company's stock.

Insider Activity

In other news, CFO Balaji Gandhi sold 28,759 shares of Phreesia stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $862,770.00. Following the completion of the sale, the chief financial officer now owns 116,174 shares in the company, valued at $3,485,220. The trade was a 19.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Allison C. Hoffman sold 1,213 shares of Phreesia stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total transaction of $28,881.53. Following the completion of the sale, the general counsel now directly owns 137,921 shares of the company's stock, valued at approximately $3,283,899.01. The trade was a 0.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 113,160 shares of company stock worth $3,139,103 in the last quarter. 5.80% of the stock is owned by corporate insiders.

Phreesia Stock Down 1.1 %

Phreesia stock opened at $24.47 on Tuesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The firm has a 50 day moving average price of $25.41 and a two-hundred day moving average price of $24.44. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of -16.65 and a beta of 0.82.

Analyst Ratings Changes

A number of equities analysts recently weighed in on PHR shares. KeyCorp reduced their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a report on Friday, January 10th. DA Davidson dropped their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and lifted their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Canaccord Genuity Group lifted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $31.33.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.